|
FY2026
12 months to May 30, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to Jun 1, 2024
|
FY2023
12 months to May 27, 2023
|
FY2022
12 months to May 28, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Unrealized foreign currency gain | |||||
| Depreciation and amortization | |||||
| Inventory provisions | |||||
| Share-based compensation expense | |||||
| Loss on disposal of property, plant and equipment | |||||
| Deferred income taxes | |||||
| (Gain) loss on disposal of healthcare assets and related charges | |||||
| Change in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from the sale of property, plant and equipment | |||||
| Proceeds from disposal of healthcare assets | |||||
| Proceeds from maturity of investments | |||||
| Purchases of investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Cash dividends paid on common and Class B common stock | |||||
| Proceeds from revolving credit facility | |||||
| Repayment of revolving credit facility | |||||
| Other | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash paid during the fiscal year: | |||||
| Income taxes, net of refunds | |||||
| Non-cash activities: | |||||
| Accruals for construction in progress | |||||
| Right of use assets obtained in exchange for lease liabilities | |||||
Loading...